Cited by 1,360Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Polycystic ovary syndrome

Norman, Robert J, Dewailly, Didier, Legro, Richard S, Hickey, Theresa E·2007·The Lancet

DOI 10.1016/s0140-6736(07)61345-2

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61345-2

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121

Show all 181 references

Research works printed but not linked: 5

Azziz, 2006, Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess Society guideline, J Clin Endocrinol Metab, 91, 4237, 10.1210/jc.2006-0178 · DOI · Paper page
Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165
Legro, 2006, Pregnancy in polycystic ovary syndrome (PPCOS) baseline characteristics: effect of race and ethnicity on the PCOS phenotype, J Soc Gynecol Investig, 13, 268a
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Hughes, 2000, Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome, Cochrane Database Syst Rev, 2

Sorted by citations

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Self-citation
Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome
Qi, X., Yun, C., Sun, L., Xia, J., Wu, Q., Wang, Y., Wang, L., Zhang, Y., Liang, X., Wang, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0509-0 · Cited by 881
Polycystic ovary syndrome
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Self-citation
Minireview: Kisspeptin/Neurokinin B/Dynorphin (KNDy) Cells of the Arcuate Nucleus: A Central Node in the Control of Gonadotropin-Releasing Hormone Secretion
Lehman, M. N., Coolen, L. M., & Goodman, R. L. (2010) · Endocrinology · doi:10.1210/en.2010-0022 · Cited by 768
The role of the gut microbiome and its metabolites in metabolic diseases
Wu, J., Wang, K., Wang, X., Pang, Y., & Jiang, C. (2020) · Protein & Cell · doi:10.1007/s13238-020-00814-7 · Cited by 592
The impact of the gut microbiota on the reproductive and metabolic endocrine system
Qi, X., Yun, C., Pang, Y., & Qiao, J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1894070 · Cited by 587
Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary
Dewailly, D., Robin, G., Peigné, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 547
Self-citation
Ovulation: Parallels With Inflammatory Processes
Duffy, D. M., Ko, C. J., Jo, M., Brännström, M., & Curry, T. E. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00075 · Cited by 530
The adverse effects of obesity on conception and implantation
Brewer, C., & Balen, A. H. (2010) · Reproduction · doi:10.1530/rep-09-0568 · Cited by 498
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
Dewailly, D., Gronier, H., Poncelet, É., Robin, G., Leroy, M., Pigny, P., Duhamel, A., & Catteau-Jonard, S. (2011) · Human Reproduction · doi:10.1093/humrep/der297 · Cited by 483
Self-citation
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P. E., Lindström, J., Lalic, N. M., Greaves, C. J., McKee, M., Kissimova‐Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 485
Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
Tata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434
Self-citation
Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome
Gibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2963 · Cited by 428
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies
Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary
Ding, N., Harlow, S. D., Randolph, J. F., Loch-Caruso, R. K., & Park, S. K. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa018 · Cited by 420
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Self-citation
Gender differences in the cardiovascular effect of sex hormones
Vitale, C., Mendelsohn, M. E., & Rosano, G. M. C. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.105 · Cited by 375
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362
Association between polycystic ovary syndrome and gut microbiota
Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., & Tang, L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153196 · Cited by 350
The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis
Ding, T., Hardiman, P. J., Petersen, I., Wang, F.-F., Qu, F., & Baio, G. (2017) · Oncotarget · doi:10.18632/oncotarget.19180 · Cited by 336
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335
Testosterone, sex hormone-binding globulin and the metabolic syndrome: A systematic review and meta-analysis of observational studies
Brand, J. S., van der Tweel, I., Grobbee, D. E., Emmelot-Vonk, M. H., & van der Schouw, Y. T. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq158 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
Hayek, S. E., Bitar, L., Hamdar, L., Mirza, F., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 342
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
Piouka, A., Farmakiotis, D., Katsikis, I., Μacut, D., Gerou, S., & Panidis, D. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90684.2008 · Cited by 316
Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 306
Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing
Gantenbein, K. V., & Kanaka-Gantenbein, C. (2021) · Nutrients · doi:10.3390/nu13061951 · Cited by 288
Effects of a Ketogenic Diet in Overweight Women with Polycystic Ovary Syndrome
Paoli, A., Mancin, L., Giacona, M. C., Bianco, A., & Caprio, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02277-0 · Cited by 281
The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome
Thomson, R. L., Buckley, J. D., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0751 · Cited by 277
Self-citation
Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris
Melnik, B. C., & Schmitz, G. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00924.x · Cited by 266
Adolescent Obesity and Puberty: The “Perfect Storm”
Jasik, C. B., & Lustig, R. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.009 · Cited by 270
Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome
Li, R., Brereton, R. E., Anderson, R. A., Wallace, A. M., & Ho, C. K. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.002 · Cited by 266
Polycystic ovary syndrome current status and future perspective
Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 273
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis
Zhao, Y., Fu, L., Li, R., Wang, L., Yan, Y., Liu, N.-N., Zhang, C., Wang, Y., Liu, P., Tu, B.-B., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-153 · Cited by 232
Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort
Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.005 · Cited by 217
Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome
Catteau-Jonard, S., Jamin, S. P., Leclerc, A., Gonzalès, J., Dewailly, D., & di Clemente, N. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1231 · Cited by 219
Self-citation
Prenatal and postnatal hormone effects on the human brain and cognition
Bonnie Auyeung, B., Lombardo, M. V., & Baron‐Cohen, S. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1268-2 · Cited by 240
Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
Sverrisdóttir, Y. B., Mogren, T., Kataoka, J., Janson, P. O., & Stener-Victorin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00725.2007 · Cited by 216
Diagnostic Criteria for Polycystic Ovary Syndrome: Pitfalls and Controversies
Lujan, M. E., Chizen, D. R., & Pierson, R. A. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32915-2 · Cited by 217
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions
Farrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209
Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome
Thomson, R. L., Buckley, J. D., Lim, S. S., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.001 · Cited by 207
Self-citation
Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome
Stener-Victorin, E., Jedel, E., Janson, P. O., & Sverrisdottir, Y. B. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2009 · Cited by 194
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments
Ng, F., Mammen, O. K., Wilting, I., Sachs, G. S., Ferrier, I. N., Cassidy, F., Beaulieu, S., Yatham, L. N., & Berk, M. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00737.x · Cited by 196
Polycystic ovary syndrome and environmental toxins
Rutkowska, A. Z., & Diamanti‐Kandarakis, E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.031 · Cited by 199
Current Knowledge of Obesity’s Effects in the Pre-and Periconceptional Periods and Avenues for Future Research
Jungheim, E. S., & Moley, K. H. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.06.043 · Cited by 190
i-HOPE: Detection And Prediction System For Polycystic Ovary Syndrome (PCOS) Using Machine Learning Techniques
Denny, A., Raj, A., Ashok, A., Ram, C. M., & George, R. (2019) · IEEE Region 10 Conference (TENCON) · doi:10.1109/tencon.2019.8929674 · Cited by 189
Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings
Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-511 · Cited by 191
Polycystic Ovary Syndrome
Nandi, A. A., Chen, Z., Patel, R., & Poretsky, L. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.003 · Cited by 189
Type 2 diabetes in the child and adolescent
Zeitler, P. S., Fu, J., Tandon, N., Nadeau, K. J., Urakami, T., Barrett, T. G., & Maahs, D. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12179 · Cited by 188
The genetics of the polycystic ovary syndrome
Urbanek, M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0400 · Cited by 185
Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies
Mills, G., Badeghiesh, A. M., Suarthana, E., Baghlaf, H. A., & Dahan, M. H. (2020) · Human Reproduction · doi:10.1093/humrep/deaa099 · Cited by 185
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
Dumont, A., Robin, G., Catteau-Jonard, S., & Dewailly, D. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0134-9 · Cited by 180
Self-citation
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 199
Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys
Abbott, D. H., Tarantal, A. F., & Dumesic, D. A. (2009) · American Journal of Primatology · doi:10.1002/ajp.20679 · Cited by 177
Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index
Jedel, E., Wærn, M., Gustafson, D., Landén, M., Eriksson, E., Holm, G., Nilsson, L., Lind, A. K., Janson, P. O., & Stener‐Victorin, E. (2009) · Human Reproduction · doi:10.1093/humrep/dep384 · Cited by 180
The Genetics of Infertility: Current Status of the Field
Zorrilla, M., & Yatsenko, A. N. (2013) · Current Genetic Medicine Reports · doi:10.1007/s40142-013-0027-1 · Cited by 176
Treatment strategies for women with polycystic ovary syndrome
Jin, P., & Xie, Y. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1395841 · Cited by 181
Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology
Liao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 178
Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche
Noordam, C., Dhir, V., McNelis, J. C., Schlereth, F., Hanley, N. A., Krone, N., Smeitink, J. A., Smeets, R., Sweep, F. C. G. J., Grinten, H. L. C.-V. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810489 · Cited by 169
A New Model of Development of the Mammalian Ovary and Follicles
Hummitzsch, K., Irving‐Rodgers, H. F., Hatzirodos, N., Bonner, W. M., Sabatier, L., Reinhardt, D. P., Sado, Y., Ninomiya, Y., Wilhelm, D., & Rodgers, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055578 · Cited by 169
Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews
Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J., & Moran, L. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13828 · Cited by 166
Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia
Boyle, J. A., Cunningham, J., OˈDea, K., Dunbar, T., & Norman, R. J. (2012) · Medical Journal of Australia · doi:10.5694/mja11.10553 · Cited by 160
Self-citation
Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes
Tal, R., Seifer, D. B., Khanimov, M., Malter, H. E., Grazi, R. V., & Leader, B. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.02.026 · Cited by 160
A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells
Qu, F., Wang, F., Yin, R., Ding, G., Elprince, M., Gao, Q., Shi, B., Pan, H.-H., Huang, Y.-T., Jin, M., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0881-4 · Cited by 156
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
Endometrial progesterone resistance and PCOS
Li, X., Feng, Y., Jin-fang, L., Billig, H., & Shao, R. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-2 · Cited by 155
Environmental determinants of polycystic ovary syndrome
Merkin, S. S., Phy, J. L., Sites, C. K., & Yang, D. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.011 · Cited by 169
Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients
Zhao, Y., Zhang, C., Huang, Y., Yu, Y., Li, R., Li, M., Liu, N., Liu, P., & Qiao, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2419 · Cited by 154
A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota
Depboylu, G. Y., & Akdevelıoğlu, Y. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1657515 · Cited by 164
Enhanced glycolysis in granulosa cells promotes the activation of primordial follicles through mTOR signaling
Zhang, X., Zhang, W., Wang, Z., Zheng, N., Yuan, F., Li, B., Li, X., Deng, L., Lin, M., Chen, X., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04541-1 · Cited by 154
Ethnic differences in the phenotypic expression of polycystic ovary syndrome
Zhao, Y., & Qiao, J. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.006 · Cited by 152
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152
Kisspeptin/Kisspeptin Receptor System in the Ovary
Hu, K.-L., Zhao, H., Chang, H., Yu, Y., & Qiao, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00365 · Cited by 153
The impact of obesity on egg quality
Purcell, S. H., & Moley, K. H. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9592-y · Cited by 150
Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
Han, Q., Wang, J., Li, W., Chen, Z., & Du, Y. (2021) · Microbiome · doi:10.1186/s40168-021-01046-5 · Cited by 156
Type 2 diabetes in children and adolescents
Rosenbloom, A. L., Silverstein, J. H., Amemiya, S., Zeitler, P. S., & KLINGENSMITH, G. J. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00584.x · Cited by 148
Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction
Li, T., Zhang, T., Gao, H., Liu, R., Gu, M., Yang, Y., Cui, T., Lu, Z., & Yin, C. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101886 · Cited by 145
A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS)
Jazani, A. M., Azgomi, H. N. D., Azgomi, A. N. D., & Azgomi, R. N. D. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00312-0 · Cited by 121
Renal denervation: a potential new treatment modality for polycystic ovary syndrome?
Schlaich, M. P., Straznicky, N. E., Grima, M. T., Sari, C. I., Dawood, T., Mahfoud, F., Lambert, É., Chopra, R., Socratous, F., Hennebry, S. C., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328344db3a · Cited by 141
Transient prenatal androgen exposure produces metabolic syndrome in adult female rats
Demissie, M., Lazić, M., Foecking, E. M., Aird, F., Dunaif, A. E., & Levine, J. E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90208.2008 · Cited by 143
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
Vassilatou, E., Lafoyianni, S., Vryonidou, A., Ioannidis, D., Kosma, L. K., Katsoulis, K., Papavassiliou, E. D., & Tzavara, I. (2009) · Human Reproduction · doi:10.1093/humrep/dep380 · Cited by 145
Type 2 diabetes mellitus in the child and adolescent
Rosenbloom, A. L., Silverstein, J. H., Amemiya, S., Zeitler, P. S., & KLINGENSMITH, G. J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00429.x · Cited by 140
Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development
Liao, B., Qi, X., Yun, C., Qiao, J., & Pang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.815968 · Cited by 141
Elastic fibers: formation, function, and fate during aging and disease
Schmelzer, C. E. H., & Duca, L. (2021) · FEBS Journal · doi:10.1111/febs.15899 · Cited by 139
Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome
Reddy, P. S., Begum, N., Mutha, S., & Bakshi, V. (2016) · Asian Pacific Journal of Reproduction · doi:10.1016/j.apjr.2016.01.006 · Cited by 138
The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility
Bedenk, J., Bokal, E. V., & Virant‐Klun, I. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01622-7 · Cited by 147
Polycystic Ovary Syndrome Detection Machine Learning Model Based on Optimized Feature Selection and Explainable Artificial Intelligence
Elmannai, H., El-Rashidy, N., Mashal, I., Alohali, M. A., Farag, S., El-Sappagh, S., & Saleh, H. (2023) · Diagnostics · doi:10.3390/diagnostics13081506 · Cited by 140
Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
Kokosar, M., Benrick, A., Perfilyev, A., Fornes, R., Nilsson, E., Maliqueo, M., Behre, C. J., Sazonova, A., Ohlsson, C., Ling, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22883 · Cited by 137
Regulatory role of microRNAs in ovarian function
Imbar, T., & Eisenberg, I. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.024 · Cited by 135
Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern
Gooren, L. J., Wierckx, K., & Giltay, E. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0011 · Cited by 136
Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk
Shi, D., & Vine, D. F. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.006 · Cited by 137
Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome
Zhao, H., Zhao, Y., Li, T., Li, M., Li, J., Li, R., Liu, P., Yu, Y., & Qiao, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.013 · Cited by 132
Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
George, J. T., Kakkar, R. K., Marshall, J., Scott, M. L., Finkelman, R. D., Ho, T. W., Veldhuis, J. D., Skorupskaite, K., Anderson, R. A., McIntosh, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1202 · Cited by 131
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases
Quaranta, G., Sanguinetti, M., & Masucci, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02653 · Cited by 131
Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers
Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128
The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review
Krul-Poel, Y. H. M., Snackey, C., Louwers, Y. V., Lips, P. T. A. M., Lambalk, C. B., Laven, J. S. E., & Şimşek, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0617 · Cited by 124
Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?
Stener‐Victorin, E., Holm, G., Labrie, F., Nilsson, L., Janson, P. O., & Ohlsson, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1908 · Cited by 126
Molecular pathways disrupted by gestational diabetes mellitus
Nguyen‐Ngo, C., Jayabalan, N., Salomón, C., & Lappas, M. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0274 · Cited by 129
Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
Sun, B., Ma, Y., Li, L., Hu, L., Wang, F., Zhang, Y., Dai, S., & Sun, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.615957 · Cited by 124

Authors: Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E.
Affiliations: The University of Adelaide (AU)
Centre Hospitalier Universitaire de Lille (FR)
Pennsylvania State University (US)
Corresponding author: Hickey, Theresa E
ORCID: Norman, Robert J
Dewailly, Didier
Legro, Richard S
Hickey, Theresa E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2007-08
Volume: 370
Issue: 9588
Pages: 685-697
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(07)61345-2
OpenAlex: W2499178053
Cited by: 1,360
References: 181
Citations by year: 2026: 43 · 2025: 61 · 2024: 100 · 2023: 100 · 2022: 101 · 2021: 105 · 2020: 94 · 2019: 86 · 2018: 86 · 2017: 74 · 2016: 78 · 2015: 70 · 2014: 62 · 2013: 52 · 2012: 60
FWCI: 6.99
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, hyperandrogenism, insulin resistance, menstrual disorders, infertility, hirsutism, acne, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, diagnostic criteria, chronic anovulation, polycystic ovary, genetic susceptibility, lifestyle factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks